Related Experiment Video
Updated: May 13, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
A Medicaid and commercial insured claims-based study to estimate improved antipsychotic medication adherence among
Bruce Pyenson1, Sara Goldberg, Kosuke Iwasaki
1Milliman, Inc., One Pennsylvania Plaza, 38th Floor, New York, NY 10119, USA. Bruce.pyenson@milliman.com
Abstract:
Compliance with antipsychotic medication is clinically important but challenging for schizophrenia patients. Clinical trials and epidemiological studies strongly suggest that improved compliance results in reduced hospitalizations and other adverse outcomes. Examination of Medicaid and commercial claim data suggests that a significant portion of schizophrenia patients have a regular pattern of visits with one outpatient professional, yet are noncompliant with their medication. For many of these patients, results show that the administration of once-monthly verifiable therapy would improve compliance.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Blind Procedures
Antidepressant Drugs: MAOIs and Other Agents
Mania and Antimanic Drugs: Overview
